Stock Events

Sage Therapeutics (SAGE) Q3 2024 Earnings

SAGE +5.37%
31JulConfirmed
Q4 2023
Q2 2024
Q1 2024
Q3 2024
-1.8
-1.38
-0.97
-0.55

Details

Expected EPS
-1.641107
Actual EPS
-1.7
Surprise EPS
-0.06
Surprise Percent
+3.59%

Description

Sage Therapeutics (SAGE) has reported earnings of -1.7 per share for Q3 2024.

0 Comments

Share your thoughts